Maya Goldman

Following Thursday's Supreme Court ruling, CMS will give states newly subject to the mandate more time to meet deadlines.

Medicare pay advisors discussed the importance of two-sided risk and administratively-set benchmarks in a reformed model.

MedPAC approved the suggestions despite concerns with labor and supply costs and the viability of the physician fee schedule.

Healthcare employers that receive Medicare and Medicaid payments must get their workers vaccinated under President Joe Biden's policy, which faces lawsuits.

The federal agency guidelines addressed women's health, HIV screenings and suicide screenings.

Stakeholder optimism about CMS' proposal to help exchange plans better predict their expenses for healthy enrollees varies.

A final decision on whether Medicare will cover the controversial drug is expected in April.

Easing access to coronavirus tests is part of President Joe Biden's pandemic response plan.

Medicare regulators will issue a preliminary decision by Wednesday on whether to approve coverage of Aduhelm.

Justices asked how the vaccine mandate is different from CMS’ other infection control policies. 

CMS also wants to reduce out-of-pocket drug costs and improve dual-eligible enrollees' Medicare Advantage experiences.

While Medicare spent $1.5 billion on COVID-19 tests in 2020, it saw a more than $1 billion dip on other test spending than in 2019.

Advocates want CMS to test out comprehensive care—and value-based payment—for Alzheimer's and dementia.

The proposal suggests prohibiting gender and sexual identity discrimination, requiring standardized plan offerings and more.

While the model was pitched as a way to lower drug prices, it didn't specify whether drugmakers would have to decrease prices for healthcare providers, meaning providers could have had to offer drugs at a financial loss.